The association between adiponectin, HDL-cholesterol and 1-antitrypsin-LDL in female subjects without metabolic syndrome

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Kotani, Kazuhiko ^a   Yamada, Toshiyuki ^a   Taniguchi, Nobuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALPHA 1 ANTITRYPSIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; TRIACYLGLYCEROL BLOOD LEVEL; ATHEROSCLEROSIS; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED; PROTEIN BINDING;

ADIPONECTIN; ADULT; AGED; ALPHA 1-ANTITRYPSIN; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOPROTEINS, LDL; METABOLIC SYNDROME X; MIDDLE AGED; PROTEIN BINDING; TRIGLYCERIDES;

EID: 78650626618     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-147     Document Type: Article

References (30)

1. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. AD Lopez CD Mathers M Ezzati DT Jamison CJ Murray, Lancet 2006 367 1747 1757 10.1016/S0140-6736(06)68770-9 16731270
2. Role of oxidized low density lipoprotein in atherogenesis. JL Witztum D Steinberg, J Clin Invest 1991 88 1785 1792 10.1172/JCI115499 1752940
3. An endothelial receptor for oxidized low-density lipoprotein. T Sawamura N Kume T Aoyama H Moriwaki H Hoshikawa Y Aiba T Tanaka S Miwa Y Katsura T Kita T Masaki, Nature 1997 386 73 77 10.1038/386073a0 9052782
4. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. AE Fraley S Tsimikas, Curr Opin Lipidol 2006 17 502 509 10.1097/01.mol.0000245255.40634.b5 16960498
5. Measurement of plasma oxidized low-density lipoprotein and its clinical implications. H Itabe M Ueda, J Atheroscler Thromb 2007 14 1 11 17332686
6. The potential of serum amyloid A - LDL as a novel biomarker for cardiovascular disease risk. K Kotani N Satoh T Yamada A Gugliucci, Clin Lipidol 2010 5 489 495 10.2217/clp.10.42
7. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. S Freigang S Hörkkö E Miller JL Witztum W Palinski, Arterioscler Thromb Vasc Biol 1998 18 1972 1982 9848892
8. Induction of glutathione synthesis by oxidized low-density lipoprotein and 1-palmitoyl-2-arachidonyl phosphatidylcholine: protection against quinone-mediated oxidative stress. DR Moellering AL Levonen YM Go RP Patel DA Dickinson HJ Forman VM Darley-Usmar, Biochem J 2002 362 51 59 10.1042/0264-6021:3620051 11829739
9. Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements. F Bea FN Hudson A Chait TJ Kavanagh ME Rosenfeld, Circ Res 2003 92 386 393 10.1161/01.RES.0000059561.65545.16 12600891
10. Dual role of oxidized LDL on the NF-kappaB signaling pathway. F Robbesyn R Salvayre A Negre-Salvayre, Free Radic Res 2004 38 541 551 10.1080/ 10715760410001665244 15346645
11. Immunomodulation of atherosclerosis with a vaccine. PK Shah KY Chyu GN Fredrikson J Nilsson, Nat Clin Pract Cardiovasc Med 2005 2 639 646 10.1038/ncpcardio0372 16306920
12. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. GH van Puijvelde AD Hauer P de Vos R van den Heuvel MJ van Herwijnen R van der Zee W van Eden TJ van Berkel J Kuiper, Circulation 2006 114 1968 1976 10.1161/CIRCULATIONAHA.106.615609 17060383
13. Oxidized low-density lipoprotein: a double-edged sword on atherosclerosis. BL Yu SP Zhao XS Huang, Med Hypotheses 2007 69 553 556 10.1016/j.mehy.2007.01.043 17368957
14. Dual effects of oxidized low-density lipoprotein on LXR-ABCA1-apoA-I pathway in 3T3-L1 cells. SP Zhao BL Yu XZ Xie SZ Dong J Dong, Int J Cardiol 2008 128 42 47 10.1016/j.ijcard.2007.05.017 17643522
15. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease. J Nilsson GN Fredrikson H Björkbacka KY Chyu PK Shah, J Intern Med 2009 266 221 231 10.1111/j.1365-2796.2009.02150.x 19702790
16. Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes. DL Knoell DR Ralston KR Coulter MD Wewers, Am J Respir Crit Care Med 1998 157 246 255 9445306
17. Activation of primary human monocytes by the oxidized form of alpha1-antitrypsin. F Moraga S Janciauskiene, J Biol Chem 2000 275 7693 7700 10.1074/jbc.275.11.7693 10713080
18. In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL. S Mashiba Y Wada M Takeya A Sugiyama T Hamakubo A Nakamura N Noguchi E Niki A Izumi M Kobayashi K Uchida T Kodama, Arterioscler Thromb Vasc Biol 2001 21 1801 1808 10.1161/hq1101.098232 11701469
19. A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome. K Kotani N Satoh Y Kato R Araki K Koyama T Okajima M Tanabe M Oishi H Yamakage K Yamada M Hattori A Shimatsu, Atherosclerosis 2009 204 526 531 10.1016/j.atherosclerosis.2008.09.017 19007930
20. Pathophysiological significance of adiponectin. M Nishida T Funahashi I Shimomura, Med Mol Morphol 2007 40 55 67 10.1007/s00795-007-0366-7 17572841
21. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Expert Panel on detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
22. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. Circ J 2002 66 987 992 10.1253/circj.66.987 12419927
23. Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease. R Lautamäki T Rönnemaa R Huupponen T Lehtimäki P Iozzo KE Airaksinen J Knuuti P Nuutila, Metabolism 2007 56 881 886 10.1016/j.metabol.2007.01.018 17570246
24. Impact of oxidative stress on plasma adiponectin in patients with chronic heart failure. T Tanaka T Tsutamoto K Nishiyama H Sakai M Fujii T Yamamoto M Horie, Circ J 2008 72 563 568 10.1253/circj.72.563 18362426
25. Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease. T Miyazaki K Shimada O Sato K Kotani A Kume K Sumiyoshi Y Sato H Ohmura Y Watanabe H Mokuno H Daida, Atherosclerosis 2005 179 139 145 10.1016/j.atherosclerosis.2004.09.013 15721020
26. Protective role of heme oxygenase in the blood vessel wall during atherogenesis. KA Hoekstra DV Godin KM Cheng, Biochem Cell Biol 2004 82 351 359 10.1139/o04-006 15181468
27. Heme oxygenase-1: unleashing the protective properties of heme. LE Otterbein MP Soares K Yamashita FH Bach, Trends Immunol 2003 24 449 455 10.1016/S1471-4906(03)00181-9 12909459
28. Cytokine signaling modules in inflammatory responses. JJ O'Shea PJ Murray, Immunity 2008 28 477 487 10.1016/j.immuni.2008.03.002 18400190
29. Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. A L'Abbate D Neglia C Vecoli M Novelli V Ottaviano S Baldi R Barsacchi A Paolicchi P Masiello GS Drummond JA McClung NG Abraham, Am J Physiol Heart Circ Physiol 2007 293 3532 3541 10.1152/ajpheart.00826.2007 17906103
30. CVD risk factors and ethnicity - a homogeneous relationship? NG Forouhi N Sattar, Atheroscler Suppl 2006 7 11 19 10.1016/j.atherosclerosissup.2006.01.003 16500156